ARCHIVES

Cediranib/Olaparib Combination Nearly Doubles PFS in Phase II

This article is from The Cancer Letter archive.

Vol. 37 No. 9 | September 26, 2014

Download PDF Visit The Full Archive

Related Articles

In Brief: Broder Resigns From IVX; Bishop To Receive Public Service Award; Johnston Rejoins NIAID

August 7, 1998

Letter To The Editor: Prevention Research Requires Rigor And Collaboration.

June 20, 2003

Advisors Ok New RFP For Natural Product Large-Scale Production

March 6, 1992

Michael Friedman To Head PhRMA’s Office Of Biomedical Preparedness.

November 2, 2001

CPT Code Changes Confuse Oncologists, Appear To Bloc Some Chemotherapy Payments

April 6, 1990

NCI Offers 200 Cell Lines to Scientist

May 6, 1983